Recent evidence indicated that high-expression of ACTA2-AS1 was positively associated with poor prognosis in COAD patients, accelerating the pathological activities via regulating miR-4644/TRIM44 [22]. This evidence concerns the gene ACTA2 and colon adenocarcinoma.